JP2013525269A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013525269A5 JP2013525269A5 JP2012556355A JP2012556355A JP2013525269A5 JP 2013525269 A5 JP2013525269 A5 JP 2013525269A5 JP 2012556355 A JP2012556355 A JP 2012556355A JP 2012556355 A JP2012556355 A JP 2012556355A JP 2013525269 A5 JP2013525269 A5 JP 2013525269A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- day
- medical food
- disorder
- dietary fiber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 51
- 238000000034 method Methods 0.000 claims description 40
- 208000030159 metabolic disease Diseases 0.000 claims description 39
- 235000013325 dietary fiber Nutrition 0.000 claims description 28
- 235000013305 food Nutrition 0.000 claims description 25
- 208000024891 symptom Diseases 0.000 claims description 22
- 208000016097 disease of metabolism Diseases 0.000 claims description 20
- 150000004676 glycans Chemical class 0.000 claims description 19
- 229920001282 polysaccharide Polymers 0.000 claims description 19
- 239000005017 polysaccharide Substances 0.000 claims description 19
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 16
- 229920002581 Glucomannan Polymers 0.000 claims description 16
- 229940046240 glucomannan Drugs 0.000 claims description 16
- 235000010493 xanthan gum Nutrition 0.000 claims description 16
- 229920001285 xanthan gum Polymers 0.000 claims description 16
- 239000000230 xanthan gum Substances 0.000 claims description 16
- 229940082509 xanthan gum Drugs 0.000 claims description 16
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 15
- 229940072056 alginate Drugs 0.000 claims description 15
- 235000010443 alginic acid Nutrition 0.000 claims description 15
- 229920000615 alginic acid Polymers 0.000 claims description 15
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 15
- 230000002265 prevention Effects 0.000 claims description 11
- 206010022489 Insulin Resistance Diseases 0.000 claims description 8
- 239000000835 fiber Substances 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 claims description 4
- 208000001145 Metabolic Syndrome Diseases 0.000 claims description 4
- 208000016222 Pancreatic disease Diseases 0.000 claims description 4
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 4
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims description 4
- 230000008816 organ damage Effects 0.000 claims description 4
- 238000011084 recovery Methods 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 230000003050 macronutrient Effects 0.000 claims description 2
- 235000021073 macronutrients Nutrition 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 235000005911 diet Nutrition 0.000 claims 1
- 230000000378 dietary effect Effects 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 description 8
- 238000006460 hydrolysis reaction Methods 0.000 description 8
- 239000002253 acid Substances 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31263010P | 2010-03-10 | 2010-03-10 | |
| US61/312,630 | 2010-03-10 | ||
| US35765810P | 2010-06-23 | 2010-06-23 | |
| US61/357,658 | 2010-06-23 | ||
| PCT/CA2011/000260 WO2011109900A1 (en) | 2010-03-10 | 2011-03-10 | Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015010059A Division JP2015083604A (ja) | 2010-03-10 | 2015-01-22 | グルコマンナン、キサンタンガム、およびアルギネートを含む、代謝性障害の処置のための食品 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013525269A JP2013525269A (ja) | 2013-06-20 |
| JP2013525269A5 true JP2013525269A5 (enExample) | 2014-04-24 |
Family
ID=44560211
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012556355A Pending JP2013525269A (ja) | 2010-03-10 | 2011-03-10 | グルコマンナン、キサンタンガム、およびアルギネートを含む、代謝性障害の処置のための食品 |
| JP2015010059A Pending JP2015083604A (ja) | 2010-03-10 | 2015-01-22 | グルコマンナン、キサンタンガム、およびアルギネートを含む、代謝性障害の処置のための食品 |
| JP2017000123A Pending JP2017074072A (ja) | 2010-03-10 | 2017-01-04 | グルコマンナン、キサンタンガム、およびアルギネートを含む、代謝性障害の処置のための食品 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015010059A Pending JP2015083604A (ja) | 2010-03-10 | 2015-01-22 | グルコマンナン、キサンタンガム、およびアルギネートを含む、代謝性障害の処置のための食品 |
| JP2017000123A Pending JP2017074072A (ja) | 2010-03-10 | 2017-01-04 | グルコマンナン、キサンタンガム、およびアルギネートを含む、代謝性障害の処置のための食品 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20110223192A1 (enExample) |
| EP (1) | EP2544696B1 (enExample) |
| JP (3) | JP2013525269A (enExample) |
| KR (1) | KR20130039726A (enExample) |
| CN (1) | CN102892421A (enExample) |
| AU (2) | AU2011226708B2 (enExample) |
| BR (1) | BR112012022799B1 (enExample) |
| CA (2) | CA2791418C (enExample) |
| NZ (1) | NZ602249A (enExample) |
| RU (1) | RU2553348C2 (enExample) |
| SG (1) | SG183543A1 (enExample) |
| WO (1) | WO2011109900A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102010039734A1 (de) * | 2010-08-25 | 2012-03-01 | Bayer Materialscience Aktiengesellschaft | Katalysator und Verfahren zur Herstellung von Chlor durch Gasphasenoxidation |
| GB201110672D0 (en) * | 2011-06-23 | 2011-08-10 | M I Drilling Fluids Uk Ltd | Wellbore fluid |
| TWI469785B (zh) * | 2012-04-25 | 2015-01-21 | Inovobiologic Inc | 用於治療代謝性疾病之膳食纖維組成物 |
| RU2672594C2 (ru) * | 2013-07-01 | 2018-11-16 | Юниверсити Оф Саутерн Калифорния | Состояние воздержания от пищи в качестве диетического лечения диабета |
| CN104277130A (zh) * | 2013-07-02 | 2015-01-14 | 中国科学院上海药物研究所 | 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途 |
| CN103604884B (zh) * | 2013-11-21 | 2015-10-28 | 南京工业大学 | 一种检测海藻生物质内还原性糖类物质的方法 |
| EP3082466B1 (en) * | 2013-12-18 | 2019-08-21 | Thylabisco AB | Use of thylakoids to reduce the urge for palatable food |
| KR20160001935A (ko) | 2014-06-30 | 2016-01-07 | 원광대학교산학협력단 | 블랙 커런트 추출물을 유효성분으로 함유하는 대사증후군의 예방, 개선 또는 치료를 위한 조성물 |
| CN104391049B (zh) * | 2014-09-20 | 2017-03-22 | 鄂尔多斯市中轩生化股份有限公司 | 黄原胶微量溶剂残留量的检测方法 |
| SMT202300091T1 (it) * | 2014-11-26 | 2023-05-12 | Omega Pharma Innovation And Dev Nv | Composizione di fibre dietetica |
| ES2857557T3 (es) * | 2015-01-26 | 2021-09-29 | Kaleido Biosciences Inc | Compuestos terapéuticos de glicano y métodos relacionados de los mismos |
| CA3224535A1 (en) * | 2016-01-12 | 2017-07-20 | University Of Southern California | Use of long-term fasting mimicking as dietary treatment for multiple myeloma and other cancers |
| US10485253B2 (en) | 2017-08-21 | 2019-11-26 | Mustapha Benmoussa | Method of microalgal biomass processing for high-value chemicals production, the resulting composition of butyrogenic algal slowly fermenting dietary fiber, and a way to improve colon health using a slowly fermenting butyrogenic algal dietary fiber |
| EP3827027A4 (en) | 2018-07-23 | 2022-04-27 | Nutragenom, LLC | COMPOSITION AND METHODS FOR GENERATE AND MAINTAIN MOLECULAR HYDROGEN (H2) IN AQUEOUS SYSTEMS |
| CN110412157A (zh) * | 2019-07-17 | 2019-11-05 | 广州金评检测研究院有限公司 | 一种烟酰胺原料中烟酸的测定方法 |
| JP7412759B2 (ja) * | 2020-04-16 | 2024-01-15 | 松谷化学工業株式会社 | 水溶性食物繊維のエネルギー量の簡便な測定方法 |
| CN112933105A (zh) * | 2021-02-10 | 2021-06-11 | 浙江工业大学 | 甘露葡萄糖醛酸多（寡）糖及硫酸化衍生物在制备治疗非酒精性脂肪肝药物中的应用 |
| CN112782321A (zh) * | 2021-03-09 | 2021-05-11 | 上海市质量监督检验技术研究院 | 一种快速检测纺织品中维生素e含量的测定方法 |
| CN117665192A (zh) * | 2023-06-30 | 2024-03-08 | 辰欣药业股份有限公司 | 一种特殊医学用途全营养配方乳剂食品中钾、钙、钠、镁的测定方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0683118B2 (ja) * | 1988-01-19 | 1994-10-19 | 日本電気株式会社 | 直流終端回路 |
| JPH02245148A (ja) * | 1989-03-17 | 1990-09-28 | Unie Koroido Kk | グルコマンナンの凝固方法及びこれに用いる組成物 |
| US5460957A (en) * | 1992-04-28 | 1995-10-24 | Maruha Corporation | Calcium alginate oligosaccharide and method for producing the same from potassium or sodium alginate |
| US20020044988A1 (en) * | 2000-08-22 | 2002-04-18 | Fuchs Eileen C. | Nutritional composition and method for improving protein deposition |
| GB0406013D0 (en) * | 2004-03-17 | 2004-04-21 | Chiron Srl | Analysis of saccharide vaccines without interference |
| US8062686B2 (en) * | 2005-04-12 | 2011-11-22 | InovoBiologics, Inc. | Dietary supplement, and methods of use |
| US8597709B2 (en) * | 2005-04-12 | 2013-12-03 | Inovobiologic Inc. | Dietary supplement and methods of use |
-
2011
- 2011-03-10 RU RU2012142237/15A patent/RU2553348C2/ru not_active IP Right Cessation
- 2011-03-10 CA CA2791418A patent/CA2791418C/en active Active
- 2011-03-10 EP EP11752778.8A patent/EP2544696B1/en active Active
- 2011-03-10 SG SG2012064176A patent/SG183543A1/en unknown
- 2011-03-10 CN CN2011800216956A patent/CN102892421A/zh active Pending
- 2011-03-10 AU AU2011226708A patent/AU2011226708B2/en active Active
- 2011-03-10 CA CA2859055A patent/CA2859055A1/en not_active Abandoned
- 2011-03-10 US US13/045,285 patent/US20110223192A1/en not_active Abandoned
- 2011-03-10 KR KR1020127026489A patent/KR20130039726A/ko not_active Ceased
- 2011-03-10 NZ NZ602249A patent/NZ602249A/en unknown
- 2011-03-10 WO PCT/CA2011/000260 patent/WO2011109900A1/en not_active Ceased
- 2011-03-10 BR BR112012022799-8A patent/BR112012022799B1/pt not_active IP Right Cessation
- 2011-03-10 JP JP2012556355A patent/JP2013525269A/ja active Pending
-
2014
- 2014-08-14 AU AU2014213536A patent/AU2014213536A1/en not_active Abandoned
-
2015
- 2015-01-22 JP JP2015010059A patent/JP2015083604A/ja active Pending
-
2017
- 2017-01-04 JP JP2017000123A patent/JP2017074072A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013525269A5 (enExample) | ||
| Chen et al. | Fuzhuan brick tea polysaccharides attenuate metabolic syndrome in high-fat diet induced mice in association with modulation in the gut microbiota | |
| US11529364B2 (en) | Synthetic composition for treating metabolic disorders | |
| RU2012142237A (ru) | Продукт, содержащий глюкоманнан, ксантановую камедь и альгинат для лечения метаболических нарушений | |
| Peshev et al. | Fructans: Prebiotics and immunomodulators | |
| Wang et al. | Regular intake of white kidney beans extract (Phaseolus vulgaris L.) induces weight loss compared to placebo in obese human subjects | |
| den Besten et al. | Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids | |
| Hu et al. | Artificial simulated saliva, gastric and intestinal digestion of polysaccharide from the seeds of Plantago asiatica L. | |
| Nie et al. | Effects of nondigestible oligosaccharides on obesity | |
| Bock et al. | Understanding how pre-and probiotics affect the gut microbiome and metabolic health | |
| US10660913B2 (en) | Compositions containing mixtures of fermentable fibers | |
| Lu et al. | Preparation of the Auricularia auricular polysaccharides simulated hydrolysates and their hypoglycaemic effect | |
| Rasmussen et al. | Prebiotics and inflammatory bowel disease | |
| Zhang et al. | Akkermansia muciniphila, an important link between dietary fiber and host health | |
| US10987368B2 (en) | Synthetic composition for preventing or treating CVD | |
| Zhou et al. | The leap of inulin fructans from food industry to medical application | |
| Gao et al. | Maternal supplementation with konjac glucomannan improves maternal microbiota for healthier offspring during lactation | |
| US20160367577A1 (en) | Synthetic composition for treating metabolic disorders | |
| US12485138B2 (en) | Prophylactic use of inulin against sinusitis | |
| US10835544B2 (en) | Synthetic composition for regulating satiety | |
| Zheng et al. | Dietary carbohydrates and the intestinal barrier: emerging insights into NF-κB modulation and health outcomes | |
| Mahdavi et al. | Cardiometabolic responses to L-carnitine in obese women with knee osteoarthritis: a randomized, double-blind, placebo-controlled pilot study | |
| WO2023161315A1 (en) | Compositions and methods for reducing the occurrence of diarrhea by promoting blautia obeum in the gut microbiota | |
| Yu et al. | Interaction between konjac glucomannan and gut microbiota and its impact on health | |
| US20140212494A1 (en) | Methods of Improving Digestive Health |